Drug Detail
Information about XmAb18087
Generic Name |
||
|---|---|---|
IND |
XmAb18087 | |
Brand Name (US) |
||
Manufacturer |
Xencor | |
Drug Type |
monoclonal antibody | |
Delivery |
Intravenous | |
Approval Status |
Phase 1 | |
Indications |
||
Overall Strategy |
Immune system | |
Strategy |
Immunotherapy | |
Drug Category |
SSTR2 + CD3 inhibitor | |
Links |
|
|
Xencor Press Release 2/22/2018 |
Trials of this drug |
|
|
A Study of XmAb®18087 in Subjects With NET and GIST |
Trial results |
|
Search for this drug/combination in: